y 27632 has been researched along with gsk 269962a in 2 studies
| Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (gsk 269962a) | Trials (gsk 269962a) | Recent Studies (post-2010) (gsk 269962a) |
|---|---|---|---|---|---|
| 1,924 | 3 | 891 | 17 | 0 | 14 |
| Protein | Taxonomy | y 27632 (IC50) | gsk 269962a (IC50) |
|---|---|---|---|
| Rho-associated protein kinase 2 | Homo sapiens (human) | 0.004 | |
| Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.049 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 3.5 | |
| RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 0.955 | |
| RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 1.35 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 1.26 | |
| Rho-associated protein kinase 1 | Homo sapiens (human) | 0.0017 | |
| Ribosomal protein S6 kinase alpha-1 | Homo sapiens (human) | 0.132 | |
| RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 1.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bamford, M; Behm, DJ; Bentley, R; Chen, Z; Doe, C; Dul, E; Grygielko, E; Hu, E; Jolivette, L; Jung, D; Khandekar, S; Kirkpatrick, R; Lafferty, R; Lee, D; Marino, JP; Panchal, T; Smith, GK; Stavenger, R; Webb, C; Willette, R; Wright, LL; Yi, T | 1 |
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
2 other study(ies) available for y 27632 and gsk 269962a
| Article | Year |
|---|---|
Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Cells, Cultured; Cytokines; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Macrophages; Male; Oxadiazoles; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho-Associated Kinases; Vasodilator Agents | 2007 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |